High-dose melphalan and autologous stem cell transplantation in multiple myeloma: efficacy and minimal residual disease’s impact on progression-free survival
Mengyuan Chen, Gang Chen, Jianli Xu, Kaile Zhang, Ruixue Yang, Chunxia Han, Jia Hou, Ming Jiang, Hailong Yuan
Springer Nature ·
2026-10-05
· DOI 10.1186/s12885-026-17060-5
The publisher did not provide an abstract — full text is available via the link below.
Mengyuan Chen, Gang Chen, Jianli Xu, Kaile Zhang, Ruixue Yang, Chunxia Han et al. High-dose melphalan and autologous stem cell transplantation in multiple myeloma: efficacy and minimal residual disease’s impact on progression-free survival. // BMC Cancer. – 2026. – DOI: 10.1186/s12885-026-17060-5. – URL: https://doi.org/10.1186/s12885-026-17060-5
Mengyuan Chen, Gang Chen, Jianli Xu, Kaile Zhang, Ruixue Yang, Chunxia Han, Jia Hou, Ming Jiang, & Hailong Yuan (2026). High-dose melphalan and autologous stem cell transplantation in multiple myeloma: efficacy and minimal residual disease’s impact on progression-free survival. BMC Cancer. https://doi.org/10.1186/s12885-026-17060-5
Mengyuan Chen, et al. “High-dose melphalan and autologous stem cell transplantation in multiple myeloma: efficacy and minimal residual disease’s impact on progression-free survival.” BMC Cancer, 2026. doi:10.1186/s12885-026-17060-5.
@article{Chen2026,
title = {High-dose melphalan and autologous stem cell transplantation in multiple myeloma: efficacy and minimal residual disease’s impact on progression-free survival},
author = {Chen, Mengyuan and Chen, Gang and Xu, Jianli and Zhang, Kaile and Yang, Ruixue and Han, Chunxia and Hou, Jia and Jiang, Ming and Yuan, Hailong},
journal = {BMC Cancer},
year = {2026},
doi = {10.1186/s12885-026-17060-5},
url = {https://doi.org/10.1186/s12885-026-17060-5}
}